What is GHK-Cu?
GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine, present in human plasma and known to decline with age. It has one of the longer research histories among peptides used in aesthetic and regenerative protocols.
Recovery & Repair
GHK‑Cu
A naturally occurring copper-binding tripeptide studied extensively in skin and connective tissue research.
- Format
- 50mg vial — injectable
- Price
- $220 per vial
- Route
- Injectable / Topical
- Evidence level
- Limited
- Regulatory status
- Compounded
- Testing
- Provider Determines Testing
Pricing reflects the compounded preparation and doctor review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
Understanding GHK-Cu
Format & administration
Available as a subcutaneous injectable or a compounded topical preparation depending on your goal. Your doctor selects the format at review.
Testing posture
Your doctor determines the final testing requirements for GHK-Cu after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
How it works
How GHK-Cu works
- 01Research has examined GHK-Cu's relationship with collagen and elastin synthesis, antioxidant activity, and the remodeling phase of wound healing, alongside its role as a copper carrier in tissue.
Show illustration: GHK-Cu
What has been studied
Potential applications and evidence
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
Explored for skin firmness, tone, and texture
Discussed within hair and scalp wellness protocols
Potential support for wound and scar remodeling
Studied for connective tissue quality
Doctor-guided
A personalized approach
Your doctor determines the final testing requirements for GHK-Cu after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status: Provider Determines Testing
Commonly reviewed at baseline
- CBC
- Comprehensive metabolic panel (CMP)
- Serum copper if clinically relevant
Follow-up & monitoring
Skin and hair response is assessed visually at follow-up. Copper status is only checked when your doctor sees a reason.
Medication review
Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Format & dosing
Available as a subcutaneous injectable or a compounded topical preparation depending on your goal. Your doctor selects the format at review.
Safety
What patients should know
- Not FDA-approved; compounded per prescription. Patients with copper metabolism disorders, including Wilson's disease, should not use this therapy.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Wilson disease or other copper-handling disorders
Regulatory status: Compounded. Evidence level: Limited. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.
Common questions
Frequently asked questions
Keep exploring
Related therapies
Recovery & Repair
BPC-157
Connective tissue repair, joint mobility, and gut healing support.
Provider Determines Testing
$220View
Recovery & Repair
TB-500
Systemic tissue repair, flexibility, and injury recovery support.
Provider Determines Testing
$210View
Recovery & Repair
BPC-157 / TB-500
Dual-action recovery stack for tissue repair and systemic healing.
Provider Determines Testing
$230View
Ready when you are
Find out what your body is actually asking for.
Fill out a short intake form and our care team will build a plan grounded in your labs — not a guess from a supplement aisle.